Advanced network care3/28/2023 "CHOP has been a leader in developing pediatric gene-based therapies, and working with our colleagues at Penn Medicine, we've taken cell and gene therapies from the bench to the bedside. Geme, M.D., physician-in-chief and chairman of the Department of Pediatrics at CHOP. "At CHOP, we're driven by a relentless commitment to discover and provide the best treatments to pediatric patients, and this program with Independence will allow us to reach patients for whom gene-based therapies could be potentially life-changing," said Joseph W. We look forward to working on this program with Independence and CHOP, which share our focus on defining the future of these life-changing therapies." "As world leaders in gene and cell therapy development, our teams at Penn Medicine are committed to ensuring that patients can count on us to provide them with cutting-edge care. Porter, M.D., director of Cell Therapy and Transplantation in Penn Medicine's Abramson Cancer Center and the Jodi Fisher Horowitz professor in Leukemia Care Excellence in the Perelman School of Medicine. "We are excited to collaborate with Independence in this important, emerging area of medicine," said David L. As pioneers of these approaches, they also have staff who are experts in the protocols established by manufacturers to ensure optimal safety and the best possible outcomes when administering the therapies to patients. Both have played pivotal roles in the development and clinical trials of first-in-the-nation gene-based therapies, which have paved the way for their approvals by the U.S. The providers in Independence's Advanced Network for Gene-Based Therapeutics include Penn Medicine and Children's Hospital of Philadelphia (CHOP). That's why we're committed to making sure our members have continued access to these important treatment options. "Gene-based therapies, although expensive, are often one-dose treatments and have so much potential to improve a person's quality of life. "We're proud to launch this new network as part of our comprehensive strategy to manage specialty drugs," said Rodrigo Cerdá, M.D, senior vice president of Health Services and chief medical officer at Independence.
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |